Research Article
Sexual Dimorphisms of Adrenal Steroids, Sex Hormones, and Immunological Biomarkers and Possible Risk Factors for Developing Rheumatoid Arthritis
Table 3
Steroidal and hormonal values reported by referral laboratory and imputed to full sample sizes.
| Steroid and hormonal statistical values | Controls () | Pre-RA cases () | All subjects () | Females | Males | Females | Males | Females | Males | () | () | () | () | () | () |
| 17-OH pregnenolone | | | | | | | Mean (nmol/L) ± SE | 6.8 ± 0.3 | 11.9 ± 0.8 | 6.8 ± 0.6 | 11.8 ± 1.1 | 6.8 ± 0.3 | 11.9 ± 0.7 | Median; IQR | 5.7; 4.4–7.9 | 10.2; 7.3–15.2 | 5.7; 4.2–8.8 | 11.0; 8.7–14.6 | 5.7; 4.4–8.2 | 10.2; 7.7–15.0 | Dehydroepiandrosterone (DHEA) | | | | | | | Mean (nmol/L) ± SE | 18.6 ± 1.0 | 8.5 ± 0.6 | 17.9 ± 1.9 | 7.6 ± 1.0 | 18.5 ± 0.9 | 8.4 ± 0.5 | Median; IQR | 15.9; 12.5–20.8 | 7.2; 4.8–10.3 | 14.8; 11.5–19.2 | 7.7; 3.9–9.7 | 15.6; 12.4–19.7 | 7.2; 4.7–10.1 | 17-OH progesterone | | | | | | | Mean (nmol/L) ± SE | 4.3 ± 0.3 | 5.0 ± 0.3 | 4.3 ± 0.5 | 5.0 ± 0.5 | 4.3 ± 0.3 | 5.0 ± 0.3 | Median; IQR | 3.0; 1.9–5.7 | 4.7; 3.1–6.3 | 3.6; 1.7–6.1 | 4.5; 3.5–6.0 | 3.1; 1.9–5.9 | 4.7; 3.2–6.2 | Androstenedione | | | | | | | Mean (nmol/L) ± SE | 7.6 ± 0.2 | 2.2 ± 0.1 | 6.7 ± 0.4 | 2.2 ± 0.2 | 7.5 ± 0.2 | 2.2 ± 0.1 | Median; IQR | 7.2; 6.2–8.8 | 2.2; 1.5–2.9 | 6.6; 5.3–8.3 | 2.2; 1.4–3.0 | 7.1; 6.0–8.6 | 2.2; 1.5–2.9 | Testosterone (T) | | | | | | | Mean (nmol/L) ± SE | 2.5 ± 0.1 | 18.3 ± 0.8 | 2.4 ± 0.2 | 19.2 ± 1.8 | 2.5 ± 0.1 | 18.5 ± 0.8 | Median; IQR | 2.3; 1.8–2.9 | 17.4; 13.7–23.3 | 2.3; 1.8–2.9 | 17.8; 13.3–24.3 | 2.3; 1.8–2.9 | 17.8; 13.6–23.5 | Estradiol (E2) | | | | | | | Mean (pmol/L) ± SE | 229.5 ± 18.2 | 65.4 ± 2.9 | 251 ± 60.7 | 69.7 ± 6.0 | 233.0 ± 19.7 | 66.2 ± 2.6 | Median; IQR | 176; 80–278 | 66.0; 48.0–80.3 | 168; 83–276 | 68; 49.0–84.3 | 173; 81–278 | 66.0; 48.0–81.0 | E2/T ratio (×103) | | | | | | | Mean ± SE | 123.0 ± 16.5 | 4.1 ± 0.3 | 134.0 ± 36.1 | 4.1 ± 0.5 | 125.2 ± 15.0 | 4.1 ± 0.2 | Median; IQR | 80.2; 37.6–138 | 3.4; 2.5–5.0 | 76.5; 27.7–151 | 4.0; 2.7–4.9 | 78.8; 35.4–138 | 3.5; 2.6–5.0 | DHEA sulfate (DHEAS) | | | | | | | Mean (μmol/L) ± SE | 3.0 ± 0.2 | 7.3 ± 0.4 | 2.5 ± 0.3 | 7.5 ± 1.1 | 2.9 ± 0.1 | 7.3 ± 0.4 | Median; IQR | 2.6; 1.6–3.9 | 6.8; 4.8–8.8 | 2.3; 1.5–3.5 | 6.2; 3.8–11.0 | 2.5; 1.6–3.8 | 6.8; 4.6–8.9 | Cortisol | | | | | | | Mean (nmol/L) ± SE | 233.4 ± 11.8 | 291.1 ± 18.7 | 245.2 ± 24.6 | 272.8 ± 35.4 | 236.8 ± 10.8 | 285.5 ± 16.7 | Median; IQR | 205; 155–285 | 255; 186–382 | 241; 143–329 | 257; 161–381 | 216; 155–286 | 255; 184–369 | Luteinizing hormone (LH) | | | | | | | Mean (IU/L) ± SE | 23.4 ± 1.8 | 5.9 ± 0.3 | 23.5 ± 3.4 | 5.8 ± 0.7 | 23.4 ± 1.6 | 5.9 ± 0.3 | Median; IQR | 15.7; 5.4–39.5 | 5.1; 4.0–6.9 | 19.6; 4.3–36.2 | 5.5; 4.0–7.2 | 17.1; 5.3–37.9 | 5.1; 4.0–7.0 | Prolactin (PRL) | | | | | | | Mean (μg/L) ± SE | 11.9 ± 0.5 | 7.0 ± 0.4 | 11.0 ± 0.8 | 8.0 ± 1.0 | 11.7 ± 0.4 | 7.2 ± 0.4 | Median; IQR | 10.4; 8.0–13.4 | 6.1; 4.6–9.0 | 9.5; 8.1–13.3 | 7.6; 4.0–11.4 | 10.1; 8.1–13.4 | 6.3; 4.6–9.7 |
|
|
Significant () differences in values between total females and males, except for cortisol () and 17-hydroxyprogesterone ().
|